A Peek at Catalyst Pharmaceuticals's Future Earnings

Catalyst Pharmaceuticals (NASDAQ:CPRX) will release its quarterly earnings report on Wednesday, 2024-11-06. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Catalyst Pharmaceuticals to report an earnings per share (EPS) of $0.30.

Anticipation surrounds Catalyst Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.30, leading to a 12.75% increase in the share price on the subsequent day.

Here's a look at Catalyst Pharmaceuticals's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.26

0.17

0.26

0.44

EPS Actual

0.56

0.38

0.53

0.49

Price Change %

13.0%

6.0%

10.0%

-2.0%

Stock Performance

Shares of Catalyst Pharmaceuticals were trading at $21.75 as of November 04. Over the last 52-week period, shares are up 74.24%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analyst Observations about Catalyst Pharmaceuticals

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals has received a total of 3 ratings from analysts, with the consensus rating ...